About Accelovance
Accelovance is a company based in Rockville (United States) founded in 2005 was acquired by Linical in March 2018. Accelovance has raised $4 million across 3 funding rounds from investors including European Union and Linical. Accelovance has completed 2 acquisitions, including Altairclinical and Ntouch Research. Accelovance operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 3 rounds
-
Latest Funding Round
$545.04 K (USD), Grant
Sep 01, 2015
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Altairclinical
& 1 more
-
Acquired by
Linical
(Mar 27, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accelovance
Accelovance has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $545.04 thousand completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accelovance
Accelovance has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Linical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Full-service CRO operations are conducted across more than 20 countries.
|
Locked | Locked | Locked |
Investor details for Accelovance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accelovance
Accelovance has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Altairclinical and Ntouch Research.
Investment portfolio details for Accelovance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Full service CRO
|
Locked | Locked | 1997 | Locked | |
|
Clinical services are provided through Altair Clinical's platform.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Accelovance
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Accelovance
Detailed financials for Accelovance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accelovance Comparisons
Peer comparison for Accelovance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accelovance
Accelovance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Accelovance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accelovance
Complete news archive for Accelovance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accelovance
Accelovance was founded in 2005.
Accelovance is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Accelovance is a funded company, having raised a total of $4M across 3 funding rounds to date.
Accelovance is a full service CRO offering a wide range of services for Phase I to IV trials. Their offerings are protocol management, project and data management, clinical trial monitoring, biostatistics, patient recruitment, regulatory affairs, pharmacovilgilance, medical writing etc., Its Clinical Call Center helps them in managing patient recruitment, retention, compliance, surveillance or safety. Accelovances Elite Monitoring service offers flexible staffing solutions based on customer requirements. Their offerings are catered to oncology, vaccines and general medicine which includes cardiovascular, dermatology, nutrition, urology, and womens health. It has offices in North America, Europe and China and partnerships in India, Asia Pacific and South America.
Accelovance's top competitors include Emmes, Syneos Health and ClinChoice.
Accelovance has made 2 acquisitions, including Altairclinical, and Ntouch Research.
Accelovance has 2 investors. Key investors include European Union, and Linical.